Article Type
Editorial
Published
Bimekizumab is mentioned in the recent report by Clarivate, Drugs to Watch in 2021, as one of the drugs to be observed in 2021. This article discusses the current status of bimekizumab.
Category: Dermatology
Article Type
Original Research
Published
The aim of the article is to describe a clinical experience aimed at increasing tolerability of dimethyl fumarate.
Article Type
Original Research
Published
This article reports experiences with tildrakizumab as they may be helpful to dermatologists to maximize the
efficiency of this therapy.
Article Type
Review
Published
This narrative review aims to deliver concise information regarding infantile haemangiomas to help facilitate clinical decisions and supplement the recommendations with up-to-date evidence.
Article Type
Review
Published
This article reviews the role of IL-13 in atopic dermatitis and the most recent data on lebrikizumab and tralokinumab.